REFERENCES

Articles on the Immune system

Abbas AK, Lichtman, AH JS (2005). Cellular and Molecular Immunology (5 th Edition). Elsevier Saunders Press.
Kenney ME, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: A stepwise progression Brain, Behavior and Immunity. 2007; 21:1009-1018.

Atopic Dermatitis Click here for more detailed information

1. Spergel JM, Paller AM. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003; 112: S118-27.
2. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006; 144: 1-9.
3. Mrabet-Dabbi S, Breuer K, Klotz M et al. Deficiency in immunoglobulin G2 antibodies against staphylococcus enterotoxin C1 defines a subgroup of patients with atopic dermatitis. Clin Exp Allergy. 2005; 35:274-81.
4. al-Mohanna F, Farhar R, Kawaasi A, et al. Inhibition of neutrophil functions by human immunoglobulin E. J Allergy Clin Immunol 1993; 92: 575-66.
5. Michaelsson G. Decreased phagocytic capacity of the neutrophil leuckocytes in patients with atopic dermatitis. Acta Derma Venereol 1973; 53: 279-82.
6. Mrowietz U, Konter U, Traut R, et al. Atopic dermatitis: influence of bacteria infections on human monocyte and neutrophil granulocyte functional activities. J Allergy Clin Immunol. 1988; 82:1027-36.
7. Rogge JL, Hamlin JM. Immunodeficiencies in severs atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976; 112:1391-6.
8. Johansson C, Eshagi H, Linder MT et al. Positive atopy patch test reaction to Malassezia furfur ina topic dermatitis correlates with T helper 2-lke peripheral blood mononuclear cell response. J Invest Dermatol. 2002; 118: 1044-51.
9. Conneely OM. Antiinflammatory activities of lactoferrin. J Amer Coll Nutri 2001; 20: 389S-395S.
10. Masson PL, Heremans JF, Schonne E, et al. Lactoferrin, iron-binding protein in neutrophilic leukocytes. J Exp Med. 1969; 130: 643.
11. Okuda M, Nakazawa T, Yamauchi K et al. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomised, double-blind, placebo-controlled study. J Infect Chemother 2005; 11(6):265-9.
12. Di Mario F, Aragona G, Dal Bo N et al. Bovine lactoferrin for Helicobacter pylori eradication: open, randomised, multicentre study. Aliment Pharmacol Ther. 2006; 23: 1235-40.
13. Yamauchi K, Hiruma M, Yamazaki N et al. Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled double-blind study. Mycoses. 2000; 43(5): 197-202.
14. King JC, Cummings GE, Guo N et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. JPGN 2007; 44: 245-251.
15. Zimecki M, Spiegal K, Wlaszczyk A et al. Lactoferrrin increases the output of neutrophil and attenuates the spontaneous production of TNF-? and IL-6 by peripheral blood cells. Arch Immunol Ther Exp 1999; 47(2):113-8.
16. Yamauchi K, Wakabayashi H, Hashimoto S et al. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv Exp Med Biol 1998; 443:261-5.
17. Paesano R, Torcia F, Berlutti F et al. Oral administration of lactoferrin increase hemoglobulin and total serum iron in pregnant women. Biochem cell Biol 2006; 84:377-380.
18. Zimecki M, Walszezyk A, Cheneau P et al. Immunoregualtory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals. Acrh Immunol Ther Exp 1998; 46(6):231-40.
19. Kato M, Hirose K, Hakzaki M, Ohno M et al 1995. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother 1995; 40: 152-156.
20. Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): Implications for cancer immunotherapy. Anticancer Res. 2002; 22:1737-1754.
21. Kanazawa M. Yoshihara K. Abe H et al. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res. 2005; 25:443-450.

Articles on stress and the changes in the immune system

Depression

Bartrop RW, Lazarus L, Lacukhurst E et al. Depressed lymphocyte function in bereavement. Lancet 1987 16, 834-836.
Bovbverg DH, Cladimardsdottir H. Familial cancer, emotional distress, and low natural cytotoxicity activity in healthy women. Ann Oncol 1993; 4: 743-752.
Cohen F, Kemeny ME, Zegans LS, Johnson P, Kearney KA, Stites DP.Immune function declines with unemployment and recovers after stressor termination.
Psychosom Med. 2007 Apr;69(3):225-34.


Sleep

Cover, H, Irwin M Immunity and depression: Insomnia, retardation and reduction in natural killer cell activity. J Behav. Med 1994; 17(2):217-223.

Age

Ershler WB, Keller ET. Age-associated increased IL-6 gene expression, late-life diseases and frailty. Annu Rev Med. 2000; 51:245-270.
Cannon JG, Fiatarone MA, Fielding RA, Evans WJ. Aging and stress-induced changes in complement activation and neutrophil mobilization.
J Appl Physiol. 1994 Jun;76(6):2616-20


Nutrition

Marcos A, Nova E, Montero A. Changes in the immune system are conditioned by nutrition. Eur J Clin Nutrition 2003; Suppl 1, 566-569.

Chronic fatigue

Racciatti D, Dalessandro M, Delle Donne L, Falasca K, Zingariello P, Paganelli R, Pizzigallo E, Vecchiet J. Study of immune alterations in patients with chronic fatigue syndrome with different etiologies. Int J Immunopathol Pharmacol. 2004;17(2 Suppl):57-62.